Paul Brennan is a Grit Daily contributor and president/CEO of NervGen Pharma Corp., a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases.
More articles by Paul Brennan
Paul Brennan
on January 7, 2021
The Acceleration of Alzheimer’s Disease Drug Innovations
Paul Brennan
on December 23, 2020
Therapeutics Innovation in the Era of a Pandemic
Paul Brennan
on November 17, 2020